Viewing Study NCT03213457


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2026-03-01 @ 12:50 PM
Study NCT ID: NCT03213457
Status: COMPLETED
Last Update Posted: 2024-12-20
First Post: 2017-07-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain
Sponsor: AbbVie
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: M14-702
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators